4
Changes in Ownership
Climb Bio, Inc. Filed Acc 0001193125-26-394357
Director sold 100,000 shares at $13.67 ($1,366,820)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Thomas Stephen Basil · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-15 | Sale : show line 1 in the form 10b5-1 | −100,000 | $13.67 | $1,366,820 | 467,969 | D |
| Open-market sales · 100,000 sh · avg $13.67 · $1,366,820 | ||||||
Loading xslF345X06/ownership.xml…